Unknown

Dataset Information

0

Induction of neutralizing antibodies against SARS-CoV-2 variants by a multivalent mRNA-lipid nanoparticle vaccine encoding SARS-CoV-2/SARS-CoV Spike protein receptor-binding domains in mice.

ABSTRACT: To address the need for multivalent vaccines against Coronaviridae that can be rapidly developed and manufactured, we compared antibody responses against SARS-CoV, SARS-CoV-2, and several variants of concern in mice immunized with mRNA-lipid nanoparticle vaccines encoding homodimers or heterodimers of SARS-CoV/SARS-CoV-2 receptor-binding domains. All vaccine constructs induced robust anti-RBD antibody responses, and the heterodimeric vaccine elicited an IgG response capable of cross-neutralizing SARS-CoV, SARS-CoV-2 Wuhan-Hu-1, B.1.351 (beta), and B.1.617.2 (delta) variants.

SUBMITTER: Zhang Q 

PROVIDER: S-EPMC11025929 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Induction of neutralizing antibodies against SARS-CoV-2 variants by a multivalent mRNA-lipid nanoparticle vaccine encoding SARS-CoV-2/SARS-CoV Spike protein receptor-binding domains in mice.

Zhang Qiong Q   Tiwari Shashi S   Wen Jing J   Wang Shaobo S   Wang Lingling L   Li Wanyu W   Zhang Lingzhi L   Rawling Stephen S   Cheng Yong Y   Jokerst Jesse J   Rana Tariq M TM  

PloS one 20240418 4

To address the need for multivalent vaccines against Coronaviridae that can be rapidly developed and manufactured, we compared antibody responses against SARS-CoV, SARS-CoV-2, and several variants of concern in mice immunized with mRNA-lipid nanoparticle vaccines encoding homodimers or heterodimers of SARS-CoV/SARS-CoV-2 receptor-binding domains. All vaccine constructs induced robust anti-RBD antibody responses, and the heterodimeric vaccine elicited an IgG response capable of cross-neutralizing  ...[more]

Similar Datasets

Unknown Induction of neutralizing antibodies against SARS-CoV-2 variants by a multivalent mRNA-lipid nanoparticle vaccine encoding SARS-CoV-2/SARS-CoV Spike protein receptor-binding domains.
| S-EPMC9094100 | biostudies-literature
Unknown Neutralizing antibodies targeting SARS-CoV-2 spike protein.
| S-EPMC7737530 | biostudies-literature
Unknown SARS-CoV-2 spike S2-specific neutralizing antibodies.
| S-EPMC10274517 | biostudies-literature
Unknown SARS-CoV-2 spike-ferritin-nanoparticle adjuvanted with ALFQ induces long-lived plasma cells and cross-neutralizing antibodies.
| S-EPMC10024299 | biostudies-literature
Unknown Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.
| S-EPMC7723407 | biostudies-literature
Unknown Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants.
| S-EPMC9902292 | biostudies-literature
Genomics Potent neutralizing antibodies against SARS-CoV-2
| EGAS00001004412 | EGA
Unknown Signatures in SARS-CoV-2 spike protein conferring escape to neutralizing antibodies.
| S-EPMC8341613 | biostudies-literature
Unknown Identification of Novel Neutralizing Monoclonal Antibodies against SARS-CoV-2 Spike Glycoprotein.
| S-EPMC8353887 | biostudies-literature
Unknown SARS-CoV-2 Spike Protein and Neutralizing Anti-Spike Protein Antibodies Modulate Blood Platelet Function.
| S-EPMC10049216 | biostudies-literature